Cambridge Investment Research Advisors’s Neos Therapeutics, Inc NEOS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$6K	–	3026
2020 Q4	$6K	Buy	+10,000	New	+$6.18K	﹤0.01%	2702

Cambridge Investment Research Advisors's NEOS Position: Q1 2021 in Review

Cambridge Investment Research Advisors sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 10,000 shares — an estimated $6K sold.

Cambridge Investment Research Advisors first reported a position in NEOS in Q4 2020 and held it in 1 quarter. The position peaked at $6K in Q4 2020. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

Cambridge Investment Research Advisors reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
Cambridge Investment Research Advisors sold 10,000 Neos Therapeutics, Inc shares in Q1 2021, an estimated $6K.
Cambridge Investment Research Advisors first reported a position in Neos Therapeutics, Inc in Q4 2020 and held it in 1 quarter.
Cambridge Investment Research Advisors's Neos Therapeutics, Inc position peaked at $6K in Q4 2020.
0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2021, filed 7 May 2021.